. 2021 Jul 22;28(10):2939–2941. doi: 10.1007/s43032-021-00681-5

Table 1.

Maternal and pregnancy outcomes in the study population

	III Trimester n 46
Age, median (range)	32 (22–42)
Mode of delivery
-VB, n (%) -CS, n (%)	32 (70) 14 (30)
Severity
-Asymptomatic, n (%) -Mild, n (%) -Moderate, n (%) -Severe/critical, n (%)	18 (39) 11 (24) 12 (26) 5 (11)
Therapy
-Antiviral, n (%) -Antibiotics, n (%) -Hydroxychloroquine, n (%) -Oxygen supply, n (%) -IMV, n (%)	12 (26) 12 (26) 11 (24) 6 (13) 1 (2)
Viremia
-Total, n -Positive, n (%)	41 2 (5)
Vaginal swab
-Total, n -Positive, n (%)	45 0 (0)
Rectal swab
-Total, n -Positive, n (%)	34 9 (27)

III Trimester
n 46

Age, median (range)

32 (22–42)

Mode of delivery

-VB, n (%)

-CS, n (%)

32 (70)

14 (30)

Severity

-Asymptomatic, n (%)

-Mild, n (%)

-Moderate, n (%)

-Severe/critical, n (%)

18 (39)

11 (24)

12 (26)

5 (11)

Therapy

-Antiviral, n (%)

-Antibiotics, n (%)

-Hydroxychloroquine, n (%)

-Oxygen supply, n (%)

-IMV, n (%)

12 (26)

11 (24)

6 (13)

1 (2)

Viremia

-Total, n

-Positive, n (%)

2 (5)

Vaginal swab

-Total, n

-Positive, n (%)

0 (0)

Rectal swab

-Total, n

-Positive, n (%)

9 (27)

VB vaginal birth, CS cesarean section, IMV invasive mechanical ventilation